Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma-Reference-Cited by-同舟云学术

Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma

Published:2022-09-24 Issue:4 Volume:12 Page:4282-4293
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Thirasastr Prapassorn¹^ORCID,Lin Heather²,Amini Behrang³^ORCID,Wang Wei‐Lien⁴,Cloutier Jeffrey M.⁴,Nassif Elise F.⁵^ORCID,Keung Emily Z.⁵^ORCID,Roland Christina L.⁵,Feig Barry⁵^ORCID,Araujo Dejka¹,Benjamin Robert S.¹^ORCID,Conley Anthony P.¹,Livingston John A.¹,Ludwig Joseph¹,Patel Shreyaskumar¹^ORCID,Ratan Ravin¹,Ravi Vinod¹^ORCID,Zarzour Maria Alejandra¹,Zhou Xiao¹,Somaiah Neeta¹^ORCID

Affiliation:

1. Department of Sarcoma Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA

2. Department of Biostatistics The University of Texas MD Anderson Cancer Center Houston Texas USA

3. Department of Musculoskeletal Imaging, Division of Diagnostic Imaging The University of Texas MD Anderson Cancer Center Houston Texas USA

4. Department of Pathology, Division of Pathology/Laboratory Medicine The University of Texas MD Anderson Cancer Center Houston Texas USA

5. Department of Surgical Oncology, Division of Surgery The University of Texas MD Anderson Cancer Center Houston Texas USA

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5298

Reference28 articles.

1. The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives

2. Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma

3. MDM2 Copy Numbers in Well-Differentiated and Dedifferentiated Liposarcoma

4. Characterization of Liposarcoma Cell Lines for Preclinical and Biological Studies

5. Histologic Subtype and Margin of Resection Predict Pattern of Recurrence and Survival for Retroperitoneal Liposarcoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular characteristics and systemic treatment options of liposarcoma: A systematic review;Biomedicine & Pharmacotherapy;2024-09

2. Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment—Progresses in Their Use in Combined Cancer Therapy;Molecules;2024-01-09

3. MDM2-p53 in liposarcoma: The need for targeted therapies with novel mechanisms of action;Cancer Treatment Reviews;2024-01

4. Identification of Differentiation-Related Biomarkers in Liposarcoma Tissues Using Weighted Gene Co-Expression Network Analysis;J BIOL REG HOMEOS AG;2023